Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
Clinical trial NCT02088983 · UNKNOWN
Trial details
- NCT number
- NCT02088983
- Sponsor
- University of Ottawa
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.